Researchers at Hadassah Hospital in Jerusalem have created a first-of-its-kind artificial intelligence program to recognize cancer-causing mutations.

“Today, we can already say that carriers of a TP53 gene mutation have an increased risk of developing cancer at an early age,” Dr. Shai Rosenberg told i24News.

“Cells in the human body where certain genetic changes have occurred are very likely to become cancer cells. Each of us carries a gene called the TP53 gene, whose function is to protect the normal cells of the body by correcting genetic changes. When too many changes occur, the gene causes a planned ‘suicide’ of the cell, thus preventing the cell from becoming cancerous,” Rosenberg explained.

The first breakthrough was published in the prominent journal Briefings in Bioinformatics.

The article states that the Israeli researchers were able “to create an unprecedented, thoroughly validated and clinically oriented classification model.”

 
JNS

Every story is a world

In an era of social media and bloggers, false news spreads like a wildfire, igniting bouts of anti-Semitism, hate crimes and even wars.

Accurate and thoughtful journalism is needed now more than ever.

Throughout the year, we have worked hard to present stories and analyses about Israel and the Jewish world when they are needed most. Our reporters strive to tell the truth when others fail to do so.

Our ability to continue creating the content you know and read depends on you.

This Rosh Hashanah, we appreciate your support.